癌診療指針のための病理診断プラクティス　食道癌・胃癌

出版社： 中山書店
著者：
発行日： 2012-02-06
分野： 臨床医学：一般  >  癌/腫瘍一般
ISBN： 9784521733357
シリーズ： 癌診療指針のための病理診断プラクティス
電子書籍版： 2012-02-06 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

19,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

19,800 円(税込)

購入する

商品紹介

腫瘍の診断において中心的役割をつとめる病理診断は，画像医学の進歩とともにその重要性を増している。本書では，病理医，臨床医が互いに理解を深められるよう，病理診断の基本を解説。また，鑑別診断の章では疾患別にフローチャートを用意して，鑑別すべき病理像も豊富に掲載し，病理医だけでなく，臨床医にも活用しやすい，実用のための書籍となっている。

目次

  • 癌診療指針のための病理診断プラクティス　食道癌・胃癌

    ―目次―

    1章　病理診断の流れとポイント

    2章　診断のための基本知識
    　上部消化管癌取扱い規約における病理診断の概説
    　上部消化管癌診断の実際
    　上部消化管癌の内視鏡診

    3章　疾患の概要と鑑別診断
    　食道癌および関連疾患
    　胃癌および関連疾患

    4章　症例の実際

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

2章 診断のための基本知識

P.12 掲載の参考文献
食道疾患研究会編. 食道癌取扱い規約. 第1版. 東京 : 金原出版 ; 1969.
 
食道疾患研究会編. 臨床・病理 食道癌取扱い規約. 第3版. 東京 : 金原出版 ; 1973.
 
日本食道疾患研究会編. 臨床・病理 食道癌取扱い規約. 第9版. 東京 : 金原出版 ; 1999.
 
日本食道学会編. 臨床・病理 食道癌取扱い規約. 第10版補訂版. 東京 : 金原出版 ; 2008.
 
Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System. Lyon : IARC Press ; 2000.
 
Sobin LH, et al. editors. TNM Classification of Malignant Tumours. 7th ed. UK : Wiley-Blackwell ; 2009.
 
中村恭一ほか. 消化管の病理と生検診断. 東京 : 医学書院 ; 2010.
 
P.18 掲載の参考文献
日本胃癌学会編. 胃癌取扱い規約. 第14版. 東京 : 金原出版 ; 2010.
 
Sobin LH, et al. editors. TNM Classification of Malignant Tumors. 7th ed. UK : Wiley-Blackwell ; 2009.
 
P.24 掲載の参考文献
日本胃癌学会編. 胃癌取扱い規約. 第14版. 東京 : 金原出版 ; 2010. p.26-41.
 
菅井有. 改定された胃生検分類の問題点. 胃生検分類における我々の考え方. 第100回日本病理学会総会 (ワークショップ). 2011. 4. 横浜.
 
中村恭一. 胃癌の構造. 第3版. 東京 : 医学書院 ; 2005. p.59-106.
 
Sugai T, et al. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples : A proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia. Pathol Int. 2004 ; 54 : 425-35.
PubMed
Sugai T, et al. Analysis of cell cycle-related proteins in gastric intramucosal differentiatedtype cancers based on mucin phenotypes : a novel hypothesis of early gastric carcinogenesis based on mucin phenotype. BMC Gastroenterol. 2010 (open access).
 
Sugai T, et al. Molecular analysis in gastric differentiated-type intramucosal and submucosal cancers. Int J Cancer. 2010 ; 127 : 2500-9.
PubMed
Sugai T, et al. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers-a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod Pathol. 2004 ; 17 : 1223-34.
PubMed
Sugai T, et al. Molecular validation of the modified Vienna classification of colorectal tumors. J Mol Diagn. 2002 ; 4 : 191-200.
PubMed
Yoo J, et al. ras Gene mutations and expression of Ras signal transduction mediators in gastric adenocarcinomas. Arch Pathol Lab Med. 2002 ; 126 : 1096-100.
PubMed
Sugai T, et al. Role of DNA aneuploidy, overexpression of p53 gene product and cellular proliferation in the progression of gastric cancer. Cytometry. 1999 ; 38 : 111-7.
PubMed
下田忠和. 胃. 向井清ほか編. 外科病理学. 第4版. 東京 : 文光堂 ; 2006 : 459-82.
 
大倉康男. 鑑別ポイント 生検. 深山正久, 大倉康男編. 取扱い規約に沿った腫瘍鑑別診断アトラス 胃. 東京 : 文光堂 ; 2009 : 227-47.
 
河内洋ほか. "横這型胃癌" の臨床病理学的特徴. 胃と腸. 2010 ; 45 : 1203-11.
 
菅井有ほか. 核異型度に基づいた腸型分化型胃粘膜内癌の分子病理学的検討-特に腸型低異型度胃癌における分子解析. 胃と腸. 2010 ; 45 : 1212-25.
 
菅井有. 胃高分化管状腺癌. 深山正久, 大倉康男編. 取扱い規約に沿った腫瘍鑑別診断アトラス 胃. 東京 : 文光堂 ; 2009 : 55-62.
 
菅井有, 中村眞一. 大腸病変における免疫染色の有用性 (臨時増刊号). 病理と臨. 2007 ; 25 : 57-64.
 
九嶋亮治ほか. 低異型度分化型胃癌の病理学的特徴-腺腫との鑑別を含めて. 胃と腸. 2010 ; 45 : 1086-96.
 
Ueyama H, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type) : proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010 ; 34 : 609-19.
PubMed
P.31 掲載の参考文献
神谷誠. グルコマンナンを用いたセルブロック作製. Medical Technology. 2007, 35 : 546-7.
Medical*Online
三宅康之ほか. 胸腹水におけるコロジオンバッグを用いたセルブロック組織診の意義. 臨床検査. 1997 ; 41 : 595-7.
 
礒田浩二ほか. 電気泳動用のアガロースを用いた簡便なセルブロック作製法. 病理と臨床. 2007 ; 25 : 1287-90.
Medical*Online
早田正和ほか. 私の工夫 サンドイッチ法を用いたアルギン酸ナトリウム・セルブロック法の工夫. 病理と臨床. 2008 ; 26 : 195.
 
山田寛, 伊藤智雄. セルブロック作製における簡便化の方法. 病理技術. 2011 ; 74 : 21-3.
 
Werling RW, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin : an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003 ; 27 : 303-10.
PubMed
Liegl B, et al. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol. 2009 ; 33 : 437-46.
PubMed
P.37 掲載の参考文献
阿部達也. 生体防御の最前線で働く粘液ムチンの性質と機能. 2009. http://www.akita-pu.ac.jp/bioresource/dbt/molb/abe/mucinrev.pdf
 
井藤久雄ほか. 病理医のための組織学の基礎. 胃. 病理と臨床. 2004 ; 22 : 189-97.
 
Filipe MI, Ramachandra S. The Histochemistry of Intestinal Mucins ; Changes in Disease. In : Whitehead R, editor. Gastrointestinal and Oesophageal Pathology. Edinburgh : Churchill Livingstone ; 1995. p73-95.
 
中山淳ほか. 胃腺粘液の組織化学と機能解析. 第94回日本病理学会総会技術講習会 (日本病理学会・日本組織細胞化学会合同) テキスト. 2005. p.45-50.
 
Ota H, et al. Application of mucin histochemistry for pathological diagnosis-expression of gastric phenotypes in metaplastic and neoplastic lesions and its relation to the organoid differentiation-. Acta Histochem Cytochem. 1995 ; 28 : 43-53.
 
松原亜季子ほか. 胃癌の亜分類と形質発現分類の意義. 病理と臨床. 2010 ; 28 : 596-605.
Medical*Online
Silva E, et al. Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch. 2002 ; 440 : 311-7.
PubMed
McIntosh GG, et al. NCL-CD10-270 : a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol. 1999 ; 154 : 77-82.
PubMed
West AB, et al. Localization of villin, a cytoskeletal protein specific to microvilli, in human ileum and colon and in colonic neoplasms. Gastroenterology. 1988 ; 94 : 343-52.
PubMed
Almeida R, et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol. 2003 ; 199 : 36-40.
PubMed
下田忠和. 胃食道接合部領域の特性とバレット食道ならびに接合部癌における最近の知見. 日消誌. 2008 ; 15 : 1309-24.
 
Warson C, et al. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Hum Pathol. 2002 ; 33 : 660-8.
PubMed
P.47 掲載の参考文献
西巻正ほか. 癌巣内に消化性潰瘍を合併する胃癌の病理組織学的分析. 日消誌. 1985 ; 82 : 2544-53.
 
P.56 掲載の参考文献
日本胃癌学会編. 胃癌治療ガイドライン. 第3版. 東京 : 金原出版 ; 2010.
 
菅井有ほか. 深達度診断の標準化. 病理と臨床. 2010 ; 28 : 635-41.
Medical*Online
河内洋. 浸潤様式の評価, 臨床意義について. 病理と臨床. 2010 ; 28 : 642-7.
 
大倉康男. 食道異型上皮の組織診断. 病理と臨床. 2010 ; 28 : 585-90.
Medical*Online
P.66 掲載の参考文献
小山恒男ほか. 第46回食道色素研究会アンケート調査報告. 転移のあったm3・sm1 食道癌の特徴. 胃と腸. 2002 ; 37 : 71-4.
 
Chiba T, et al. Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma ; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection. Dis Esophagus. 2010 ; 23 : 398-407.
PubMed
Gotoda T, et al. Incidence of lymph node metastasis from early gastric cancer ; estimation with a large number of cases at two large centers. Gastric cancer. 2000 ; 3 : 219-25.
 
P.72 掲載の参考文献
日本食道学会編. 食道癌診断・治療ガイドライン2007年版. 東京 : 金原出版 ; 2007.
 
Kuge K, et al. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg. 2003 ; 125 : 1343-9.
 
Mine S, et al. Tumor laterality is related to prognosis in patients with esophageal squamous cell carcinoma results from a pilot study. Dis Esophagus. 2010 ; 23 : 46A.
 
Takubo K, et al. Early squamous cell carcinoma of the oesophagus : the Japanese viewpoint. Histopathology. 2007 ; 51 : 733-42.
PubMed
真能正幸ほか. 食道m3・sm1癌の臨床病理. 胃と腸. 2002 ; 37 (1) : 11-7.
 
小山恒男ほか. 転移のあったm3・sm1食道癌の特徴. 胃と腸. 2002 ; 37 : 71-4.
 
幕内博康ほか. 食道m3・sm1癌の治療成績. EMRと手術の長期予後. 胃と腸. 2002 ; 37 (1) : 53-63.
 
日本胃癌学会編. 胃癌治療ガイドライン医師用2010年10月改訂第3版. 東京 : 金原出版. 2010.
 
岩本淳一ほか. ESD施行早期胃癌における未分化型癌混在病変の検討. Prog Digest Endosc. 2008 ; 73 (2) : 54-7.
 
渡辺玄ほか. 未分化型混在早期胃癌の病理学的特徴と問題点. リンパ節転移と肉眼的特徴. 胃と腸. 2007 ; 42 (11) : 1577-87.
 
Hirasawa T, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early cancer. Gastric Cancer. 2009 ; 12 : 148-52.
PubMed
P.82 掲載の参考文献
UICC日本委員会TNM委員会訳. TNM悪性腫瘍の分類 日本語版第7版. 東京 : 金原出版 ; 2010.
 
Morita M, et al. Advances in esophageal cancer surgery in Japan : An analysis of 1000 cosecutive patients treated at a single institute. Surgery. 2008 ; 143 : 499-508.
 
Rice TW, et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg. 2003 ; 125 : 1103-13.
PubMed
Maruyama K, et al. Gastric cancer treated in Japan : Data analysis of nationwide registry. Gastric Cancer. 2006 ; 9 : 51-66.
PubMed
Novotny AR, et al. Predicting individual survival after gastric cancer resection : validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg. 2006 ; 243 : 74-81.
 
P.88 掲載の参考文献
有馬美和子ほか. 前癌病変の色素内視鏡診断. 消化器内視鏡. 2006 ; 18 : 443-52.
 
千野修ほか. 早期食道癌存在診断・質的診断の進歩. 胃と腸. 2008 ; 10 : 1431-41.
 
友利彰寿. 癌の深達度診断-食道. 田尻久雄, 小山恒男編. 症例で身につける消化器内視鏡シリーズ 食道・胃・十二指腸診断. 東京 : 羊土社 ; 2009.
 
八尾恒良ほか. 胃癌の浸潤範囲の内視鏡診断. 胃と腸. 1972 ; 7 : 725-37.
 
八尾恒良ほか. 胃の陥凹型SM 癌の病理組織構築と対比した内視鏡所見-pSM2 癌診断のための観察方法と診断限界. 胃と腸. 2008 ; 7 : 1109-25.
 
中原慶太ほか. 早期胃癌の肉眼型-決め方・考え方とその典型像 1) 0I型, 0IIa型. 胃と腸. 2009 ; 4 : 507-21.
 
Yao K, et al. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009 ; 41 : 462-7.
PubMed
長浜孝. ESD 時代の早期胃癌の内視鏡診断-側視鏡を用いた分化型早期胃癌の術前精密検査と拡大内視鏡について. 第22回日本消化器内視鏡学会九州セミナー. 2009 : 7-11.
 
中村恭一. 胃癌の構造. 第3版. 東京 : 医学書院 ; 2005.
 
P.94 掲載の参考文献
Sano Y, et al. New diagnostic method based on color imaging using narrow-band imaging (NBI) system for gastrointestinal tract [abstract]. Gastrointest Endosc. 2001 ; 53 : 125.
 
Sambongi M, et al. Analysis of spectral reflectance using normalization method from endoscopic spectroscopy system. Optical Review. 2002 ; 9 : 238-43.
 
Gono K, et al. Endoscopic observation of tissue by narrowband illumination. Optical Review. 2003 ; 10 : 211-5.
 
Gono K, et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 2004 ; 9 (3) : 568-77.
PubMed
P.99 掲載の参考文献
Yokoyama A, et al. Risk of squamous cell carcinoma of the upper aerodigestive tract in cancer- free alcoholic Japanese men : an endoscopic follow-up study. Cancer Epidemiol Biomerkers Prev. 2006 ; 15 : 2209-15.
 
Yokoyama A, et al. Multiple cancers associated with esophageal and oropharyngolaryngeal squamous cell carcinoma and the aldehyde dehydrogenase-2 genotype in male Japanese drinkers. Cancer Epidemiol Biomakers Prev. 2002 ; 11 : 895-900.
 
Yokoyama A, et al. Risk appraisal and endoscopic screening for esophageal squamous cell carcinoma in Japanese populations. Esophagus. 2007 ; 4 : 135-43.
 
Muto M, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging : A multi center randomized controlled trial. J Clin Oncol. 2010 ; 28 : 1566-72.
 
佐野寧ほか. 狭帯化RGB filter内蔵narrow band imaging (NBI) systemの開発・臨床応用. 胃と腸. 2001 ; 36 : 1283-7.
 
Muto M, et al. Narrowband imaging : a new diagnostic approach to visualize angiogenesis in superficial neoplasia. Clin Gastroenterol Hepatol. 2005 ; 3 : S16-20.
PubMed
Muto M, et al. Narrow band imaging combined with magnified endoscopy for the cancer at the head and neck region. Dig Endoscopy. 2005 ; 17 : S23-4.
 
Muto M, et al. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer. 2004 ; 101 : 1375-81.
PubMed
Ishihara R, et al. Significance of each narrow-band imaging finding in diagnosing squamous mucosal high-grade neoplasia of the esophagus. J Gastroenterol Hepatol. 2010 ; 25 : 1410-5.
PubMed
井上晴洋ほか. 早期食道癌の深達度診断の進歩. 胃と腸. 2008 ; 43 : 1479-88.
 
有馬美和子ほか. 早期食道癌深達度診断の進歩. 胃と腸. 2008 ; 43 : 1489-98.
 
P.104 掲載の参考文献
日本胃癌学会編. 胃癌治療ガイドライン. 第3版. 東京 : 金原出版 ; 2010. p.17-9.
 
Kaise M, et al. Magnifying endoscopy combined with narrow-band imaging for differential diagnosis of superficial depressed gastric lesions. Endoscopy. 2009 ; 39 : 310-5.
 
Nakamura M, et al. The usefulness of magnifying endoscopy with narrow-band imaging to distinguish carcinoma in flat elevated lesions in the stomach diagnosed as adenoma by using biopsy samples. Gastrointest Endosc. 2010 ; 71 : 1070-5.
PubMed
Nakayoshi T, et al. Magnifying endoscopy combined with narrow band imaging system for early gastric cancer : Correlation of vascular pattern with histopathology (including video). Endoscopy. 2004 ; 36 : 1080-4.
PubMed
吉田幸永ほか. 拡大内視鏡による分類 胃 血管パターン分類. 胃と腸. 2007 ; 41 : 45-51.
 
Otsuka Y, et al. Usefulness of magnifying endoscopy in the diagnosis of early gastric cancer. Endoscopy. 2004 ; 36 : 165-9.
PubMed
Kaise M, et al. Magnifying endoscopy with NBI in the diagnosis of superficial gastric neoplasia and its application for ESD. Advanced Digestive Endoscopy 2008. USA : Blackwell Publishing : 104-20.
 
Kumagai Y, et al. Magnifying chromoendoscopy of the esophagus : in-vivo pathological diagnosis using an endocytoscopy system. Endoscopy. 2004 ; 36 : 590-4.
PubMed
P.110 掲載の参考文献
Kies MS, et al. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer. 1987 ; 60 : 2156-60.
PubMed
Ajani JA, et al. Prolonged chemotherapy for localized squamous cell carcinoma of the esophagus. Eur J Cancer. 1992 ; 28A : 880-4.
PubMed
Iizuka T, et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus : Japan Esophageal Oncology Group Trial. Jpn J Clin Oncol. 1992 ; 22 : 172-6.
 
Hayashi K, et al. Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus : a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407). Jpn J Clin Oncol. 2001 ; 31 : 419-23.
PubMed
Igaki H, et al. A randomized trial of post-operative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). J Clin Oncol. 2008 ; 26 ; suppl abstr 4510.
 
Gebski V, et al. Survival benefits from neoadjuvant chenoradiotherapy or chemotherapy in oesophageal carcinoma : a meta-analysis. Lancet Oncol. 2007 ; 8 ; 226-34.
 
Adachi Y, et al. Pathology and prognosis of gastric carcinoma well versus poorly differentiated type. Cancer. 2000 ; 89 ; 1418-24.
PubMed
Yoshida M, et al. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study. Jpn J Clin Oncol. 2004 ; 34 : 654-9.
PubMed
Boku N, et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer : a randomized phase 3 study. Lancet Oncol. 2009 ; 10 ; 1063-9.
PubMed
Koizumi W, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial) : a phase III trial. Lancet Oncol. 2008 ; 9 ; 215-21.
 
Bang YJ, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA) : a phase 3, open-label, randomised controlled trial. Lancet. 2010 ; 376 ; 687-97.
 
P.114 掲載の参考文献
Kloppel G. Tumour biology and histopathology of neuroendocrine tumours. Best Pract Clin Res Endocrinol Metab. 2007 ; 21: 15-31.
PubMed
Rosai J. Rosai and Ackerman's Surgical Pathology. 9th ed. Mosby. 2004 ; 815-6.
 
伊藤正男, 井村裕夫ほか編. 医学大辞典. 第2版. 東京 : 医学書院 ; 2009.
 
Greenson JK, editor. Diagnostic Pathology Gastrointestinal. Salt Lake City : Amirsys Inc ; 2010.
 
日本胃癌学会編. 胃癌取扱い規約. 第14版. 東京 ; 金原出版 : 2010. p.36-7.
 
藤盛孝博. 消化管の病理学. 第2版. 東京 : 医学書院 ; 2008.
 
藤盛孝博ほか. 胃癌診断に必要な病理の組織-内視鏡摘除材料の病理診断のために-. 消化器内視鏡. 2010 ; 22 (1) : 18-36.
 
笹川力, 大坂道敏ほか. ヒトのGEP内分泌系の細胞とそのホルモン. 医学のあゆみ. 1973 ; 84 (9) : 499-507.
 
P.122 掲載の参考文献
大橋明子ほか. State of the art. GISTの臨床病理と分子生物学の最前線. 胃がんperspective. 2010 ; 3 (4) : 24-34.
 
廣田誠一. 病理診断に役立つ分子生物学. 第2部 病理診断医になじみのある疾患関連分子. KIT (解説編). 病理と臨床. 臨時増刊号. 2011 ; 29 : 169-73.
 
廣田誠一. 病理診断に役立つ分子生物学. 第2部 病理診断医になじみのある疾患関連分子. KIT (診断編). 病理と臨床. 臨時増刊号. 2011 ; 29 : 174-80.
 
P.129 掲載の参考文献
Rohatiner A, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994 ; 5 : 397-400.
PubMed
Ruskone-Fourmestraux A, et al. Paris staging system for primary gastrointestinal lymphomas. Gut. 2003 ; 52 : 912-3.
PubMed
Ghai S, et al. Primary Gastrointestinal Lymphoma : Spectrum of Imaging Findings with Pathologic Correlation. RadioGraphics. 2007 ; 27 : 1371-88.
PubMed
Psyrri A, et al. Primary extranodal lymphomas of stomach : clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008 ; 19 : 1992-9.
 
Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment : what has changed over the past 10 years? Br J Haematol. 2007 ; 136 : 521-38.
PubMed
Ferreri AJ, Montalban C. Primary diffuse large B-cell lymphoma of the stomach. Crit Rev Oncol Hematol. 2007 ; 63 : 65-71.
PubMed
Zucca E, Dreylin M. Gastric marginal zone lymphoma of MALT type : ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 ; 20 : iv113-4.
 
Inagaki H. Mucosa-associated lymphoid tissue lymphoma : molecular pathogenesis and clinicopathological significance. Pathol Int. 2007 ; 57 : 474-84.
PubMed
Salar A, et al. Gastrointestinal Involvement in Mantle Cell Lymphoma : A Prospective Clinic, Endoscopic, and Pathologic Study. Am J Surg Pathol. 2006 ; 30 : 1274-80.
PubMed
Leoncini L, et al. Burkitt lymphoma. In : Swerdlow SH, Harris NL, et al. editors. WHO classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press ; 2008. p.262-4.
 
Nakamura S, et al. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma. Clin Cancer Res. 2008 ; 15 : 3002-10.
 
Iwamuro M, et al. Endoscopic features and prognoses of mantle cell lymphoma with gastrointestinal involvement. World J Gastroenterol. 2010 ; 16 : 4661-9.
PubMed
Yamamoto S, et al. Gastrointestinal follicular lymphoma : review of the literature. J Gastroenterol. 2010 ; 45 : 370-88.
PubMed
P.142 掲載の参考文献
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000 ; 100 (1) : 57-70.
PubMed
Akagi I, et al. SnoN overexpression in predictive of poor survival in patients with esophageal squamous cell carcinoma. Ann Surg Oncol. 2009 ; 15 : 2965.
 
Sugimoto T, et al. The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer. 2009 ; 48 : 132-42.
PubMed
Lai LA, et al. Deletion at fragile site is a common and early event in Barrett's esophagus. Mol Cancer Res. 2010 ; 8 : 1084-94.
PubMed
Buffart TE, et al. Gastric cancers in young and elderly patients show different genomic profiles. J Pathol. 2007 ; 211 : 45-51.
 
He L, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005 ; 435 : 828-33.
PubMed
Volinia S, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006 ; 103 (7) : 2257-61.
PubMed
Seo JH, et al. Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription-polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer. Am J Clin Oncol. 2005 ; 28 (1) : 24-9.
PubMed
Ikeguchi M, Kaibara N. Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today. 2005 ; 35 (6) : 436-41.
PubMed
Illert B, et al. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Scand J Gastroenterol. 2005 ; 40 (7) : 843-9.
PubMed
Uen YH, et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. Clin Chim Acta. 2006 ; 367 (1-2) : 55-61.
 
Pituch-Noworolska A, et al. Circulating tumour cells and survival of patients with gastric cancer. Anticancer Res. 2007 ; 27 (1B) : 635-40.
PubMed
Kosaka Y, et al. Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood. Br J Cancer. 2007 ; 96 (11) : 1723-8.
 
Szatanek R, et al. Detection of isolated tumour cells in the blood and bone marrow of patients with gastric cancer by combined sorting, isolation and determination of MAGE-1, -2 mRNA expression. Oncol Rep. 2008 ; 19 (4) : 1055-60.
 
Mimori K, et al. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res. 2008 ; 14 (9) : 2609-16.
PubMed
Mimori K, et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol. 2008 ; 15 (10) : 2934-42.
PubMed
Yie SM, et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Anticancer Res. 2007 ; 27 (1B) : 535-9.
 
Zhou H, et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med. 2010 ; 88 (7) : 709-17.
 
Ikoma D, et al. Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer. Ann Surg Oncol. 2008 ; 15 (11) : 3073-82.
 
Setoyama T, et al. Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer. Br J Surg. 2007 ; 94 (8) : 984-91.
 
Liu Z, et al. Circulating tumor cells in perioperative esophageal cancer patients : quantitative assay system and potential clinical utility. Clin Cancer Res. 2007 ; 13 (10) : 2992-7.
PubMed
Bellone G, et al. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence. Ann Surg Oncol. 2007 ; 14 (11) : 3232-42.
PubMed
Hashimoto T, et al. Circulating micrometastases of esophageal cancer detected by carcinoembryonic antigen mRNA reverse transcriptase-polymerase chain reaction : clinical implications. Dis Esophagus. 2008 ; 21 (8) : 690-6.
PubMed
Cao M, et al. Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Clin Exp Metastasis. 2009 ; 26 (7) : 751-8.
PubMed
Tanaka K, et al. CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after resection in patients with esophageal cancer. Ann Surg Oncol. 2010 ; 17 (10) : 2779-86.
PubMed
Sasako M, et al. Gastric Cancer Working Group report. Jpn J Clin Oncol. 2010 ; 40 Suppl 1 : i28-37.
 
Milano F, et al. Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery. PLoS One. 2010 ; 5 (8) : e12424.
PubMed

3章 疾患の概要と鑑別診断

P.150 掲載の参考文献
Seremetis MG, et al. Leiomyomata of the esophagus. An analysis of 838 cases. Cancer. 1976 ; 38 : 2166-77.
PubMed
Adler RH, et al. Papilloma of the esophagus. Association with hiatal hernia. J Thorac Surg. 1959 ; 37 : 625-35.
PubMed
Takeshita K, et al. Clinicopathological characteristics of esophageal squamous papillomas in Japanese patients with comparison of findings from western countries. Acta Histochem Cytochem. 2006 ; 39 : 23-30.
PubMed
Weinstock JV, Kawanishi H. Gastrointestinal polyposis with orocutaneous hamartomas (Cowden's disease). Gastroenterology. 1978 ; 74 : 890-5.
PubMed
石黒信吾. 食道. 向井清ほか編. 外科病理学. 第4版. 東京 : 文光堂 ; 2006. p.397-426.
 
中村恭一ほか. 消化管の病理と生検診断. 東京 : 医学書院 ; 2010. p.40-3, 83-5.
 
坂本穆彦ほか. 標準病理学. 第4版. 東京 : 医学書院 ; 2010. p.417-23.
 
P.158 掲載の参考文献
Vakil N, et al. The Montreal definition and classification of gastroesophageal reflux disease : a global evidence-based consensus. Am J Gastroenterol. 2006 ; 101 : 1900-20.
PubMed
Carlsson R, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998 ; 33 : 1023-9.
PubMed
Shimoyama Y, et al. Diagnosis of gastroesophageal reflux disease using a new questionnaire. J Gastroenterol Hepatol. 2005 ; 20 : 643-7.
PubMed
Lundell LR, et al. Endoscopic assessment of oesophagitis : clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999 ; 45 : 172-80.
PubMed
Johnsson F, et al. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1998 ; 33 : 15-20.
PubMed
P.163 掲載の参考文献
星原芳雄. GERDとBarrett食道-診断基準の国際的相違と問題点-. 消化器内視鏡. 2009 ; 21 (8) : 1145-52.
Medical*Online
Greenson JK編. Diagnostic Pathology Gastrointestinal. Salt Lake City : Amirsys Inc ; 2010.
 
GERD研究会編. 本郷道夫監. GERDガイドラインの策定に向けて. 東京 : ヴァンメディカル ; 2007.
 
藤盛孝博. 消化管の病理学. 第2版. 東京 : 医学書院 ; 2008.
 
P.167 掲載の参考文献
Cameron AJ. Epidemiology of Barrett's esophagus and adenocarcinoma. Dis Esophagus 2002 ; 15 : 106-8.
PubMed
小山恒男ほか. Barrett食道癌の境界を読む. 胃と腸. 2004 ; 39 : 1243-9.
 
小山恒男ほか. Barrett食道およびBarrett食道癌の拡大観察. 臨消内科. 2006 ; 21 : 407-13.
 
日本食道学会編. 食道癌診断・治療ガイドライン 2007年4月版. 東京 : 金原出版 ; 2007.
 
Bollschweiler E, et al. High Rate of Lymph-Node Metastasis in Submucosal Esophageal Squamous-Cell Carcinomas and Adenocarcinomas. Endoscopy. 2006 ; 38 : 149-56.
PubMed
Shaheen NJ, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009 ; 28 ; 360 (22) : 2277-88.
 
Oyama T, et al. Endoscopic Submucosal Dissection on Early Esophageal cancer. Clin Gastroenterology and Hepatology. 2005 ; S67-70.
 
田沼徳真ほか. Barrett食道・Barrett食道癌の内視鏡診断. 臨消内科. 2008 ; 23 : 153-61.
 
Muto M, et al. Early Detection of Superficial Squamous Cell Carcinoma in the Head and Neck Region and Esophagus by Narrow Band Imaging : A Multicenter Randomized Controlled Trial. J Clin Oncol. 2010 ; 28 : 1566-72.
PubMed
P.173 掲載の参考文献
Gabbert HE, et al. Squamous cell carcinoma of esophagus. In : Hamilton SR, Aaltone LA, editors. WHO Classification of Tumors. Pathology and Genetics. Tumor of the Digestive System. Lyon : IARC Press ; 2000.
 
下田忠和. 食道の異形成dysplasiaの考え方と臨床的取り扱い. 病理と臨床. 2007 ; 25 : 687-92.
Medical*Online
八尾隆史ほか. 食道上皮内扁平上皮癌とintraepithelial neoplasiaの鑑別. 胃と腸. 2009 ; 44 : 1741-8.
 
大倉康男. 食道癌取扱い規約に定義された上皮内腫瘍の病理組織学的検討. 胃と腸. 2009 ; 44 : 1735-40.
 
八尾隆史. 消化管の前癌病変の病理診断. 日消誌. 2010 ; 107 : 1723-51.
 
藤盛孝博. 消化管の病理学. 東京 : 医学書院 ; 2004.
 
河内洋ほか. 食道上皮内腫瘍性病変の組織像と遺伝子異常. 胃と腸. 2007 ; 42 : 173-86.
 
P.177 掲載の参考文献
Bosman FT, et al. editors. WHO Classification of Tumours of the Digestive System. World Health Organization Classification of Tumours. Lyon : IARC Press ; 2010.
 
井出博子. 特殊組織型の食道癌. 病理の立場から : 肉眼診断を中心に. 胃と腸. 2005 ; 40 : 279-87.
 
幕内博康ほか. 特殊組織型の食道癌-内視鏡の立場から. 胃と腸. 2005 ; 40 : 320-36.
 
八尾隆史ほか. 特殊組織型食道癌の病理組織学的・免疫組織学的特徴. 胃と腸. 2005 ; 40 : 288-300.
 
Yachida S, et al. Adenosquamous carcinoma of the esophagus. Clinicopathological study of 18 cases. Oncology. 2004 ; 66 : 218-25.
PubMed
P.190 掲載の参考文献
がん研究振興財団. がんの統計. 2009年版.
 
日本食道疾患研究会編. 食道癌治療ガイドライン. 東京 : 金原出版 ; 2002.
 
日本食道学会編. 食道癌診断・治療ガイドライン 2007年4月版. 東京 : 金原出版 ; 2007.
 
桑野博行. 食道癌. 杉本恒明, 小俣政男ほか編. 内科学. 第9版. 東京 : 朝倉書店 ; 2007.
 
Ando N, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus : a Japan Clinical Oncology Group Study-JCOG 9204. J Clin Oncol. 2003 ; 21 : 4592-6.
 
Igaki H, et al. A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). J Clin Oncol. 2008 ; 26 (suppl) : abstr 4510.
 
Muro K, et al. A phase II study of chemoradiotherapy in patients with stage II, III esophageal squamous cell carcinoma (ESCC) : (JCOG 9906). Proc Am Soc Clin Oncol. 2007 ; 25 : 18s (abstr 15137).
 
桑野博行編. エキスパートが伝える食道外科up-to-date. 東京 : 中外医学社 ; 2010.
 
P.204 掲載の参考文献
Joel KG, editor. Diagnostic Pathology: Gastrointestinal. 1st ed. Salt Lake City : Amirsys ; 2010.
 
Cecilia M, et al. Gastrointestinal Pathology : An Atlas and Text. 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2007.
 
Robert DO, John RG, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. 2nd ed. Philadelphia : Saunders ; 2009.
 
Srivastava A, Lauwers GY. Pathology of non-infective gastritis. Histopathology. 2007 ; 50 : 15-29.
PubMed
Lauwers GY, et al. Pathology of non-Helicobacter pylori gastritis : extending the histopathologic horizons. J Gastroenterol. 2010 ; 45 : 131-45.
PubMed
Chow DK, Sung JJ. Non-NSAID non-H. pylori ulcer disease. Best Pract Res Clin Gastroenterol. 2009 ; 23 : 3-9.
PubMed
Torrente F, et al. Focal-enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacter pylori gastritis. Am J Gastroenterol. 2004 ; 99 : 598-605.
PubMed
Christine A, et al. Gastorointestinal and Liver Pathology. 2nd ed. ELSEVIER ; 2011. p.86.
 
P.218 掲載の参考文献
村上忠重, 鈴木武松. 病理─胃・十二指腸潰瘍のすべて. 東京 : 南江堂 ; 1971. p.79-102.
 
中村恭一. 胃癌の構造 (第3版). 東京 : 医学書院 ; 2005.
 
中村恭一ほか. 現代病理学大系 消化管 I 第12巻A. 東京 : 中山書店 ; 1984.
 
P.225 掲載の参考文献
日本胃癌学会編. 胃癌取扱い規約. 第14版. 東京 : 金原出版 ; 2010. p.26, 33-4, 42-3, 66-8.
 
九嶋亮治. 管状腺腫 (腸型・胃型). 深山正久ほか編. 胃癌. 腫瘍病理鑑別診断アトラス. 東京 : 文光堂 ; 2009. p.38-48.
 
滝澤登一郎. 胃の病理形態学. 東京 : 医学書院 ; 2003. p.162-8.
 
喜納勇. 胃腺腫. dysplasia, 異型上皮巣. 病理と臨床. 1991 ; 9 (臨時増刊号) : 264.
 
Bosman FT, et al. ed. WHO classification of tumours of the digestive system. Lyon : IARC ; 2010. p.10-2, 46-58.
 
Nakamura K, et al. Depressed adenoma of the stomach. Cancer. 1988 ; 62 : 2197-202.
PubMed
Kolodziejczyk P, et al. Long term follow-up study of patients with gastric adenomas with malignant transformation. Cancer. 1994 ; 74 : 2896-907.
PubMed
Schlemper RJ, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000 ; 47 : 251-5.
PubMed
Vieth M, et al. Pyloric gland adenoma : a clinico-pathological analysis of 90 cases. Virchows Arch. 2003 ; 442 : 317-21.
PubMed
Abraham SC, et al. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol. 2003 ; 16 : 786-95.
PubMed
Minematsu H, et al. Evaluation of mucin expression patterns in gastric borderline (group III) lesions. J Gastroenterol. 2006, 41 : 547-53.
PubMed
Kushima R, et al. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer. 2006 ; 9 : 177-84.
PubMed
Chen ZM, et al. Pyloric gland adenoma. An entity distinct from gastric foveolar type adenoma. Am J Surg Pathol. 2009 ; 33 : 186-93.
PubMed
九嶋亮治ほか. 胃腺腫の病理診断, 特に胃型 (幽門腺型) 腺腫について. 胃と腸. 2003 ; 38 : 1377-87.
 
P.230 掲載の参考文献
Lauwers GY, et al. Gastric Carcinoma. WHO Classification of Tumors of the Digestive System. Bosman FT, et al (eds). Lyon : IARC Press ; 2010. p.48-58.
 
深山正久, 大倉康男編. 腫瘍病理鑑別診断アトラス 胃癌. 東京 : 文光堂 ; 2009.
 
P.236 掲載の参考文献
深山正久, 大倉康男編. 腫瘍病理鑑別診断アトラス 胃癌. 東京 : 文光堂 ; 2009.
 
九嶋亮治. 特殊型胃癌の病理像と臨床的特徴. 胃と腸. 2010 ; 45 (12) : 1867-8.
 
P.241 掲載の参考文献
Appleman HD. Localized and extensive expansions of the gastric mucosa : mucosal polyps and giant folds. In : Appleman HD, editor. Pathology of the Esophagus, Stomach, and Duodenum. New York : Churchill Livingstone ; 1984. p.104-19.
 
Bluth RF, et al. Immunolocalization of transforming growth factor-α in normal and diseased human gastric mucosa. Hum Pathol. 1995 ; 26 : 1333-40.
 
Daniel ES, et al. The Cronkhite-Canada syndrome. An analysis of clinical and pathological features and therapy in 55 patients. Medicine (Baltimore). 1982 ; 61 : 293-309.
PubMed
Komorowski RA, Caya JG. Hyperplastic gastropathy. Clinicopathologic correlation. Am J Surg Pathol. 1991 ; 15 : 577-85.
PubMed
Takagi H, et al. Hypertrophic gastropathy resembling Menetrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest. 1992 ; 90 : 1161-7.
PubMed
浜田勉ほか. びまん浸潤型胃癌と鑑別を要する炎症性病変. 胃と腸. 2002 ; 37 (13) : 1687-99.
 
斉藤康晴ほか. スキルス胃癌と鑑別を要する非腫瘍性疾患-巨大皺襞性胃炎. 胃と腸. 2010 ; 45 (4) : 550-5.
 
樋口勝彦ほか. Helicobacter pylori除菌療法にて改善した胃巨大皺襞症の1例. 胃と腸. 2002 ; 37 (13) : 1741-6.
 
八尾恒良ほか. 胃悪性リンパ腫の集計成績. 胃と腸. 1980 ; 15 : 906-8.
 
Lewin KJ, Appleman HD. Tumors of the esophagus and stomach. Washington : AFIP ; 1996.
 
Mills SE, et al. Sternberg's Diagnostic Surgical Pathology. Philadelphia : Lippincott Williams & Wilkins ; 2000.
 
P.248 掲載の参考文献
磨井正義, 望月福治. 胃疾患のX線・内視鏡診断と臨床病理 陥凹型早期胃癌の診断の要点. 東京 : 医学書院 ; 1993. p.19-23.
 
中村恭一. 胃癌の構造. 第3版. 東京 : 医学書院 ; 2005. p.59-106.
 
磨井正義, 望月福治. 胃疾患のX線・内視鏡診断と臨床病理 悪性所見に乏しいIIc型早期胃癌. 東京 : 医学書院 ; 1993. p.26-8.
 
吉川時弘ほか. 早期癌と術前診断された進行胃癌症例の検討. 日消外会誌. 1990 ; 23 : 2221-6.
 
貝原信明ほか. いわゆる早期胃癌類似進行癌. 胃と腸. 1986 ; 21 : 867-71.
 
磨井正義, 望月福治. 胃疾患のX線・内視鏡診断と臨床病理 Malignant cycleとは. 東京 : 医学書院 ; 1993. p.24-5.
 
吉野正. 悪性リンパ腫. 深山正久, 大倉康男編. 取り扱い規約に従った腫瘍鑑別診断アトラス 胃. 東京 : 文光堂 ; 2009. p.171-82.
 
P.253 掲載の参考文献
日本胃癌学会編. 胃癌治療ガイドライン. 改訂第3版. 東京 : 金原出版 ; 2010.
 
Macdonald JS, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001 ; 345 : 725-30.
PubMed
Cunningham D, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006 ; 355 : 11-20.
PubMed
Sakuramoto M, et al. Adjuvant chemotherapy for gastric cancer with S -1, an oral fluoropyrimidine. N Engl J Med. 2007 ; 357 : 1810-20.
 
Boku N, et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer : randomized phase 3 study. Lancet Oncology. 2009 ; 10 : 1063-9.
PubMed
Koizumi W, et al. S-1 plus cisplatin versus S-1 alone for the first-line treatment of advanced gastric cancer (SPIRITS trial) : a phase III trial. Lancet Oncol. 2008 ; 9 : 215-21.
 
Tsuburaya A, et al. Update result on the 2.5-year follow-up of GC0301/TOP-002 : Randomized phase III study of irinotecan plus S-1 (IRI-S) versus S-1 alone as first-line treatment for advanced gastric cancer (AGC). J Clin Oncol. 2009 ; 27 : 4544.
 
Bang J, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA) : a phase 3, open-label, randomized controlled trial. Lancet. 2010 ; 28 : 687-97.
 

4章 症例の実際

P.258 掲載の参考文献
Ueyama H, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type) : proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010 ; 34 : 609-19.
PubMed
八尾隆史ほか. 新しいタイプの胃癌-胃底腺型胃癌 : 臨床病理学的特徴と発育進展様式および悪性度. 胃と腸. 2010 ; 45 (7) : 1192-202.
 
P.288 掲載の参考文献
川元健二ほか. 腫瘍性・腫瘍様十二指腸小病変の診断. 胃と腸. 2001 ; 36 : 1507-27.
 
稲土修嗣ほか. 十二指腸疾患の拡大内視鏡診断. 胃と腸. 2007 ; 42 : 753-61.
 
稲土修嗣. 十二指腸隆起性病変の通常観察・NBI・拡大内視鏡による鑑別診断. 消化器内視鏡. 2009 ; 21 : 1523-9.
Medical*Online
Onozato Y, et al. Magnifying endoscopic findings of early duodenal adenocarcinoma in relation to the pathological findings. Endoscopy. 2008 ; 40 Suppl 2 : E92-3.
 
郷田憲一ほか. 十二指腸隆起性病変アトラス 腺癌. 消化器内視鏡. 2009 ; 21 : 1560-2.
 
十二指腸の小病変. 胃と腸. 2001 ; 36 (12).
 
消化管の拡大内視鏡観察 2007. 胃と腸. 2007 ; 42 (5).
 
十二指腸隆起性病変をみたら. 消化器内視鏡. 2009 ; 21 (10).
Medical*Online
松井敏幸, 岩下明徳監. 八尾建史著. 胃拡大内視鏡. 東京 : 日本メディカルセンター ; 2009.
 

書評

最近チェックした商品履歴

Loading...